Home Companies Catalysts Deep Dives

Myeloproliferative neoplasms

Oncology · 2 drugs · 2 indications

Competitive Landscape (2 drugs)
DrugCompanyMechanismModalityRouteStage
Zilovertamab vedotinMRKROR1-directed (vedotin payload)ADCIVPHASE3
BomedemstatMRKLSD1 inhibitorSmall moleculePOPHASE3
Indications (2)
MCL
Zilovertamab vedotin PHASE3
Myelofibrosis
Bomedemstat PHASE3
Data from Supabase · Updated 2026-03-24